Stereotactic body radiation therapy for non-small cell lung cancer tumors greater than 5 cm: Safety and efficacy

International Journal of Radiation Oncology Biology Physics

Volumn 92, Issue 2, 2015, Pages 325-331

  Woody, Neil M ^a   Stephans, Kevin L ^a   Marwaha, Gaurav ^a   Djemil, Toufik ^a   Videtic, Gregory M M ^a  

^a TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL ORGANS; DISEASE CONTROL; DISEASES; DRUG PRODUCTS; POSITRON EMISSION TOMOGRAPHY; TOXICITY; TUMORS;

COMMON TERMINOLOGY CRITERIA; ENDOBRONCHIAL ULTRASONOGRAPHIES; FLUORODEOXYGLUCOSE-POSITRON EMISSION TOMOGRAPHIES; FORCED EXPIRATORY VOLUME IN 1; KAPLAN-MEIER ESTIMATES; NON SMALL CELL LUNG CANCER; PULMONARY FUNCTION TEST; STEREOTACTIC BODY RADIATION THERAPY;

RADIOTHERAPY;

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; ATELECTASIS; BODY MASS; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHARLSON COMORBIDITY INDEX; CHEST WALL PAIN; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; ENDOBRONCHIAL ULTRASONOGRAPHY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; INOPERABLE CANCER; KARNOFSKY PERFORMANCE STATUS; LOCAL RECURRENCE FREE SURVIVAL; LUNG COMPLICATION; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; MALE; MULTIMODALITY CANCER THERAPY; NON SMALL CELL LUNG CANCER; NORMAL VALUE; OVERALL SURVIVAL; PATIENT SAFETY; PLEURA EFFUSION; PNEUMONIA; PRIMARY TUMOR; PRIORITY JOURNAL; RADIATION INJURY; RADIATION RESPONSE; STEREOTACTIC BODY RADIATION THERAPY; THORAX DISEASE; THORAX PAIN; TREATMENT FAILURE; TREATMENT OUTCOME; ADENOCARCINOMA; ADVERSE EFFECTS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; LUNG NEOPLASMS; MIDDLE AGED; MORTALITY; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RADIATION DOSE FRACTIONATION; RADIOSURGERY; RETROSPECTIVE STUDY; SAFETY; SCINTISCANNING; SECONDARY; TUMOR VOLUME; VERY ELDERLY;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; BODY MASS INDEX; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; HUMANS; KARNOFSKY PERFORMANCE STATUS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROPORTIONAL HAZARDS MODELS; RADIOSURGERY; RETROSPECTIVE STUDIES; SAFETY; TUMOR BURDEN;

EID: 84928938595     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2015.01.045     Document Type: Article

References (34)

1. R. Timmerman, R. Paulus, and J. Galvin Stereotactic body radiation therapy for inoperable early stage lung cancer JAMA 303 2010 1070 1076
2. P. Baumann, J. Nyman, and M. Hoyer Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy J Clin Oncol 27 2009 3290 3296
3. L. Kestin, I. Grills, and M. Guckenberger Dose-response relationship with clinical outcome for lung stereotactic body radiotherapy (SBRT) delivered via online image guidance Radiother Oncol 110 2014 499 504
4. A. Chi, Z. Liao, and N.P. Nguyen Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: Clinical implications Radiother Oncol 94 2010 1 11
5. S. Edge, D. Byrd, C. Compton, A. Fritz, F. Greene, and A. Trotti AJCC Cancer Staging Handbook 7th ed 2010 Springer Chicago, IL 299
6. N.E. Dunlap, J.M. Larner, and P.W. Read Size matters: A comparison of T1 and T2 peripheral non-small-cell lung cancers treated with stereotactic body radiation therapy (SBRT) J Thorac Cardiovasc Surg 140 2010 583 589
7. I.S. Grills, A.J. Hope, and M. Guckenberger A collaborative analysis of stereotactic lung radiotherapy outcomes for early-stage non-small-cell lung cancer using daily online cone-beam computed tomography image-guided radiotherapy J Thorac Oncol 7 2012 1382 1393
8. G. Marwaha, K.L. Stephans, and N.M. Woody Lung stereotactic body radiation therapy: Regional nodal failure is not predicted by tumor size J Thorac Oncol 9 2014 1693 1697
9. A. Takeda, E. Kunieda, and N. Sanuki Dose distribution analysis in stereotactic body radiotherapy using dynamic conformal multiple arc therapy Int J Radiat Oncol Biol Phys 74 2009 363 369
10. S.K. Nath, A.P. Sandhu, and D. Kim Locoregional and distant failure following image-guided stereotactic body radiation for early-stage primary lung cancer Radiother Oncol 99 2011 12 17
11. Z. Allibhai, M. Taremi, and A. Bezjak The impact of tumor size on outcomes after stereotactic body radiation therapy for medically inoperable early-stage non-small cell lung cancer Int J Radiat Oncol Biol Phys 87 2013 1064 1070
12. B.P. Rowe, D.J. Boffa, and L.D. Wilson Stereotactic body radiotherapy for central lung tumors J Thorac Oncol 7 2012 1394 1399
13. Bezjak A. Seamless phase I/II study of stereotactic lung radiotherapy (SBRT) for early stage, centrally located, non-small cell lung cancer (NSCLC) in medically inoperable patients. Available at: 3/6/2014;2014: http://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?study=0813. Accessed December 19, 2014.
14. R.E. Dales, R.M. Stark, and S. Raman Computed tomography to stage lung cancer: Approaching a controversy using meta-analysis Am Rev Respir Dis 141 1990 1096 1101
15. C.J. Haasbeek, F.J. Lagerwaard, and B.J. Slotman Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer J Thorac Oncol 6 2011 2036 2043
16. J.A. Howington, M.G. Blum, and A.C. Chang Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American college of chest physicians evidence-based clinical practice guidelines Chest 143 5 Suppl 2013 e278S e313S
17. G.M. Videtic, K. Stephans, and C. Reddy Intensity-modulated radiotherapy-based stereotactic body radiotherapy for medically inoperable early-stage lung cancer: Excellent local control Int J Radiat Oncol Biol Phys 77 2010 344 349
18. R. Timmerman, R. McGarry, and C. Yiannoutsos Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer J Clin Oncol 24 2006 4833 4839
19. F.J. Lagerwaard, N.E. Verstegen, and C.J. Haasbeek Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer Int J Radiat Oncol Biol Phys 83 2012 348 353
20. S.C. Immerman, R.M. Vanecko, and W.A. Fry Site of recurrence in patients with stages I and II carcinoma of the lung resected for cure Ann Thorac Surg 32 1981 23 27
21. J.P. Wisnivesky, C. Henschke, and T. McGinn Prognosis of stage II non-small cell lung cancer according to tumor and nodal status at diagnosis Lung Cancer 49 2005 181 186
22. P.M. Gould, J.A. Bonner, and T.E. Sawyer Patterns of failure and overall survival in patients with completely resected T3 N0 M0 non-small cell lung cancer Int J Radiat Oncol Biol Phys 45 1999 91 95
23. C. Doddoli, B. D'Journo, and F. Le Pimpec-Barthes Lung cancer invading the chest wall: A plea for en-bloc resection but the need for new treatment strategies Ann Thorac Surg 80 2005 2032 2040
24. C.G. Robinson, T.A. DeWees, and I.M. El Naqa Patterns of failure after stereotactic body radiation therapy or lobar resection for clinical stage I non-small-cell lung cancer J Thorac Oncol 8 2013 192 201
25. E.M. Noordijk, C.E. van der Poest, and J. Hermans Radiotherapy as an alternative to surgery in elderly patients with resectable lung cancer Radiother Oncol 13 1988 83 89
26. J. Bradley, M.V. Graham, and K. Winter Toxicity and outcome results of RTOG 9311: A phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma Int J Radiat Oncol Biol Phys 61 2005 318 328
27. S. Sura, E. Yorke, and A. Jackson High-dose radiotherapy for the treatment of inoperable non-small cell lung cancer Cancer J 13 2007 238 242
28. J.T. Lucas Jr., J.G. Kuremsky, and M. Soike Comparison of accelerated hypofractionation and stereotactic body radiotherapy for stage 1 and node negative stage 2 non-small cell lung cancer (NSCLC) Lung Cancer 85 2014 59 65
29. G.M. Strauss, J.E. Herndon II, and M.A. Maddaus Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group study groups J Clin Oncol 26 2008 5043 5051
30. J.P. Pignon, H. Tribodet, and G.V. Scagliotti Lung adjuvant cisplatin evaluation: A pooled analysis by the LACE collaborative group J Clin Oncol 26 2008 3552 3559
31. Y. Chen, W. Guo, and Y. Lu Dose-individualized stereotactic body radiotherapy for T1-3N0 non-small cell lung cancer: Long-term results and efficacy of adjuvant chemotherapy Radiother Oncol 88 2008 351 358
32. Kloecker GH. STEREOtactic radiation and chemotherapy in lung cancer (STEREO). Available at: 2014;12/18/2014: https://clinicaltrials.gov/ct2/show/NCT01300299. Accessed December 19, 2014.
33. C.H. Hsieh, H.T. Chang, and S.C. Lin Toxic risk of stereotactic body radiotherapy and concurrent helical tomotherapy followed by erlotinib for non-small-cell lung cancer treatment-case report BMC Cancer 10 2010 696
34. S.K. Padda, B.M. Burt, and N. Trakul Early-stage non-small cell lung cancer: Surgery, stereotactic radiosurgery, and individualized adjuvant therapy Semin Oncol 41 2014 40 56